Institute of Cell Therapy,
Bone Marrow Transplantation Lab,
Department of Medicine,
Institute of Cell Therapy, Bone Marrow Transplantation Lab, Department of Medicine
Alexandros Spyridonidis has not added Biography.
If you are Alexandros Spyridonidis and would like to personalize this page please email our Author Liaison for assistance.
DNA chimerism and its consequences after allogeneic hematopoietic cell transplantation.
Chimerism Jan, 2011 | Pubmed ID: 21547035
Outcomes and prognostic factors of adults with acute lymphoblastic leukemia who relapse after allogeneic hematopoietic cell transplantation. An analysis on behalf of the Acute Leukemia Working Party of EBMT.
Leukemia Jun, 2012 | Pubmed ID: 22290066
DNA damage and repair in epithelium after allogeneic hematopoietic stem cell transplantation.
International journal of molecular sciences Nov, 2012 | Pubmed ID: 23443095
Lack of LCAT reduces the LPS-neutralizing capacity of HDL and enhances LPS-induced inflammation in mice.
Biochimica et biophysica acta Oct, 2015 | Pubmed ID: 26170061
The β-globin Replicator greatly enhances the potential of S/MAR based episomal vectors for gene transfer into human haematopoietic progenitor cells.
Scientific reports Jan, 2017 | Pubmed ID: 28106085
Simple in vitro generation of human leukocyte antigen-G-expressing T-regulatory cells through pharmacological hypomethylation for adoptive cellular immunotherapy against graft-versus-host disease.
Cytotherapy Apr, 2017 | Pubmed ID: 28162915
Stage-Specific Human Induced Pluripotent Stem Cells Map the Progression of Myeloid Transformation to Transplantable Leukemia.
Cell stem cell Mar, 2017 | Pubmed ID: 28215825
How much immunosuppression do we need?
Blood Mar, 2017 | Pubmed ID: 28280046
Plasma and Serum Metabolite Association Networks: Comparability within and between Studies Using NMR and MS Profiling.
Journal of proteome research Jul, 2017 | Pubmed ID: 28517934
Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells.
Nature medicine Mar, 2018 | Pubmed ID: 29431743
Ectopic Lck expression in CLL demarcates intratumoral subpopulations with aberrant B-cell receptor signaling.
Blood advances Apr, 2018 | Pubmed ID: 29669754
Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients.
Bone marrow transplantation Jun, 2020 | Pubmed ID: 31996792
Management of patients with acute lymphoblastic leukemia in routine clinical practice: Minimal residual disease testing, treatment patterns and clinical outcomes in Belgium, Greece and Switzerland.
Leukemia research Apr, 2020 | Pubmed ID: 32135394
Correction: Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients.
Bone marrow transplantation Jun, 2020 | Pubmed ID: 32144364
Clinical practice recommendation on hematopoietic stem cell transplantation for acute myeloid leukemia patients with -internal tandem duplication: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Haematologica Jun, 2020 | Pubmed ID: 32241850
Remdesivir and tocilizumab: Mix or match.
Journal of medical virology Jan, 2021 | Pubmed ID: 32492200
Anti-SARS-CoV-2 Antibody Responses in Convalescent Plasma Donors Are Increased in Hospitalized Patients; Subanalyses of a Phase 2 Clinical Study.
Microorganisms Nov, 2020 | Pubmed ID: 33260775
"Cerberus" T Cells: A Glucocorticoid-Resistant, Multi-Pathogen Specific T Cell Product to Fight Infections in Severely Immunocompromised Patients.
Frontiers in immunology , 2020 | Pubmed ID: 33537032
Accurate SARS-CoV-2 seroprevalence surveys require robust multi-antigen assays.
Scientific reports Mar, 2021 | Pubmed ID: 33758278
Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemia.
Bone marrow transplantation Jul, 2022 | Pubmed ID: 35501565
Impact of Cytogenetic Risk on Outcomes of Non-T-Cell-Depleted Haploidentical Hematopoietic Cell Transplantation in Patients with Relapsed or Refractory Acute Myeloid Leukemia.
Transplantation and cellular therapy Nov, 2022 | Pubmed ID: 36031079
Should anti-thymocyte globulin be added in post-transplant cyclophosphamide based matched unrelated donor peripheral blood stem cell transplantation for acute myeloid leukemia? A study on behalf of the Acute Leukemia Working Party of the EBMT.
Bone marrow transplantation Dec, 2022 | Pubmed ID: 36071114
Correction to: Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemia.
Bone marrow transplantation Dec, 2022 | Pubmed ID: 36207624
To Transplant or Not To Transplant in First Remission Acute Lymphoblastic Leukemia? Study group data give some answers, but not all.
Transplantation and cellular therapy Dec, 2022 | Pubmed ID: 36470611
Is a third SARS-CoV-2 vaccine dose efficient in allogeneic haematopoietic cell transplant recipients?
British journal of haematology Apr, 2023 | Pubmed ID: 36477621
Reduced 8-Gray Compared to Standard 12-Gray Total Body Irradiation for Allogeneic Transplantation in First Remission Acute Lymphoblastic Leukemia: A Study of the Acute Leukemia Working Party of the EBMT.
HemaSphere Jan, 2023 | Pubmed ID: 36698616
Impact of measurable residual disease on outcomes of unrelated donor haematopoietic cell transplantation with post-transplant cyclophosphamide in AML in first complete remission.
British journal of haematology Jun, 2023 | Pubmed ID: 36949658
Empowering the Potential of CAR-T Cell Immunotherapies by Epigenetic Reprogramming.
Cancers Mar, 2023 | Pubmed ID: 37046597
Solid tumor transmission from donor to recipient after allogeneic stem cell transplantation: it is rare but it happens!
Blood transfusion = Trasfusione del sangue Sep, 2023 | Pubmed ID: 37146299
Total body irradiation versus busulfan based intermediate intensity conditioning for stem cell transplantation in ALL patients >45 years-a registry-based study by the Acute Leukemia Working Party of the EBMT.
Bone marrow transplantation Aug, 2023 | Pubmed ID: 37147469
Study protocol: Phase I/II trial of induced HLA-G regulatory T cells in patients undergoing allogeneic hematopoietic cell transplantation from an HLA-matched sibling donor.
Frontiers in medicine , 2023 | Pubmed ID: 37275377
Allogeneic hematopoietic cell transplantation for patients with AML aged 70 years or older in first remission. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT).
Bone marrow transplantation Sep, 2023 | Pubmed ID: 37386253
Thiotepa-busulfan-fludarabine Compared to Treosulfan-based Conditioning for Haploidentical Transplant With Posttransplant Cyclophosphamide in Patients With Acute Myeloid Leukemia in Remission: A Study From the Acute Leukemia Working Party of the EBMT.
HemaSphere Oct, 2023 | Pubmed ID: 37746158
关于 JoVE
版权所属 © 2024 MyJoVE 公司版权所有,本公司不涉及任何医疗业务和医疗服务。